Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Interferon Maintenance in CLL or MM
NCT00004040Phase 2Withdrawn
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Start
- Jun 1998
- Primary completion
- Jun 1999
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in chronic lymphocytic leukemia (CLL), multiple myeloma (MM), sponsored by Hoag Memorial Hospital Presbyterian. Planned start Jun 1998; status: withdrawn.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia (CLL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00004040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004040.